Back

Passive and active demethylation in immune diseases with proliferation driving global hypomethylation

Shimada, M.; Omae, Y.; Hitomi, Y.; Honda, Y.; Kodama, T.; Honda, M.; Tokunaga, K.; Miyagawa, T.

2025-04-29 genomics
10.1101/2025.04.25.650620 bioRxiv
Show abstract

Global hypomethylation is frequently reported in immune-mediated diseases; however, its extent and underlying mechanisms are largely unknown. By examining seven immune-mediated diseases, we found that most exhibited global hypomethylation, particularly at CpGs in the solo-WCGW context -- sequences lacking neighboring CpGs (W = A/T) -- which are prone to passive demethylation during cell division. The hypomethylated solo-WCGW CpGs were predominantly located in transcriptionally repressed regions, potentially reflecting increased immune cell proliferation. Meanwhile, the majority of CpGs demethylated in response to TNF- and TGF-{beta} were located in transcriptionally active regions. Focusing on hypomethylated non-solo-WCGW CpGs in active regions enabled the identification of key immune-related transcription factors, such as BATF in narcolepsy and multiple sclerosis. Unlike conventional epigenome-wide association studies analyzing all CpGs, our classification-based approach, excluding CpGs susceptible to passive demethylation, could help identify CpGs more relevant to disease pathogenesis and may offer a new standard framework for future analyses.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.